Upgrade to SI Premium - Free Trial

Citi Reiterates Buy Rating on Emerson (EMR)

November 5, 2024 8:22 AM
Citi analyst Andrew Kaplowitz reiterated a Buy rating and $128.00 price target on Emerson (NYSE: EMR).The analyst comments "EMR reported ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles